Stay updated on Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page.

Latest updates to the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page
- Check3 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThis page update is a minor site revision (v3.4.2) with removal of an older government funding notice and of the previous revision notice; the study details and core content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check39 days agoChange DetectedAdded a site-wide notice about government funding status and NIH Clinical Center operations, and updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check46 days agoChange DetectedAdded a 'Show glossary' option and updated footer metadata to Revision: v3.4.0, replacing the prior capitalization and older version (v3.3.4).SummaryDifference0.2%

- Check60 days agoChange DetectedThe page shows Revision: v3.3.4, replacing the earlier Revision: v3.3.3. This appears to be an administrative update to the page version and does not modify the study details.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded the Locations section with Kansas sites (Fairway and Westwood) and updated the revision to v3.3.3; removed the HHS Vulnerability Disclosure link and the Kansas Locations entry.SummaryDifference0.2%

Stay in the know with updates to Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page.